The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of genetic variants in wnt signaling pathway to predict gender and tumor location dependent survival in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (BEV).
Yan Ning
No relevant relationships to disclose
Wu Zhang
No relevant relationships to disclose
Dongyun Yang
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
Takeru Wakatsuki
No relevant relationships to disclose
Sebastian Stintzing
No relevant relationships to disclose
Nico Benjamin Volz
No relevant relationships to disclose
Joseph Ethan Li
No relevant relationships to disclose
Rita Elie El-Khoueiry
No relevant relationships to disclose
Melissa Janae Labonte
No relevant relationships to disclose
Chiara Cremolini
No relevant relationships to disclose
Federica Marmorino
No relevant relationships to disclose
Afsaneh Barzi
No relevant relationships to disclose
Anthony B. El-Khoueiry
No relevant relationships to disclose
Heinz-Josef Lenz
Consultant or Advisory Role - Genentech (U)
Honoraria - Genentech
Michael Kahn
No relevant relationships to disclose